Abbott invites you to their event

ATTD 2023 Rethinking Treatment Limits with Sensor-Based Technology

About this event

Watch our distinguished panel of world-renowned experts reshape the conversation on sensor-based technology!

In this interactive forum, moderated by journalist and TV presenter Stephen Dixon, panelists and the audience will share views on:

  • Practical tips to help late digital adopters get the most out of advanced sensor-based technology, gaining new insights from real patient cases.
  • Considerations on when to start sensor-based interventions in the type 2 patient's journey, with considerations from a multidisciplinary care team.
  • The benefits of the automated insulin delivery* and integrated smart pen that ease the burden of diabetes management for our patients.

Excited? Watch this robust discussion as we rethink treatment limits with sensor-based technology – online now!

This symposium took place at ATTD 2023 on February 23rd in Berlin. After registering, you will receive an email with a link to watch the event on-demand, whenever you have time.

*. mylife™ Loop™ is now authorized to work with Abbott's FreeStyle Libre 3 sensor in Germany. A roll-out to further EMEA countries is planned. Please contact your Local Abbott representative for further information.

This platform is specific for ATTD/2023 International Congress, Abbott products availability may vary by country. Not all features are available in all markets. If you require product information for a specific country, please refer to your local Abbott website.

© 2023 Abbott. All rights reserved. FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are property of their own respective owners.

ADC-67108 v1.0 03/23



Hosted by

  • Guest speaker
    G
    Prof. Bernhard Kulzer (DE)

    Psychological Therapist, Diabetes Center Bad Mergentheim, Research Institute Diabetes-Academy Mergentheim (FIDAM), University Bamberg

  • Guest speaker
    G
    Prof. Samuel Seidu (UK)

    Clinical Professor in Primary Care Diabetes and Cardio-metabolic Medicine, Diabetes Research Centre, University of Leicester, Leicester General Hospital

  • Guest speaker
    G
    Stephen Dixon (UK)

    Journalist and TV presenter, living with type 1 diabetes for 31 years

  • Guest speaker
    G
    Prof. Jochen Seufert (DE)

    Head of Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg

  • Guest speaker
    G
    Dr. Jackie Elliott (UK)

    Senior Clinical Lecturer and Honorary Consultant, University of Sheffield, Sheffield Teaching Hospitals

  • Guest speaker
    G
    Prof. Ramzi Ajjan (UK)

    Professor of Metabolic Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds and Leeds Teaching Hospitals Trust

  • Guest speaker
    G
    Prof. Jean-Pierre Riveline (FR)

    Head of Department of Endocrinology and Diabetology, Lariboisière Hospital, Paris, Institut Necker Enfants Malades, INSERM U1151, CNRS UMR 8253, IMMEDIAB Laboratory, Paris

Abbott

At Abbott, we’re focused on making breakthrough technology accessible and approachable for all. Our sensing technology has revolutionized how people monitor glucose and provides doctors with more data for better informed treatment decisions